Allegra

Be sure to inform your doctor of all your medical conditions before you begin taking a medication. Some conditions can affect how you should take this medication.

Drowsiness: Fexofenadine usually causes minimal drowsiness when used as directed by your doctor or pharmacist. Studies have shown that fexofenadine does not cause drowsiness under normal circumstances. People taking higher-than-recommended doses of fexofenadine may experience drowsiness. Do not drive or operate machinery if you become drowsy while taking this medication.

Reduced kidney function: People with reduced kidney function may need to take lower doses of this medication. If you have reduced kidney function, consult your doctor or pharmacist before taking this medication.

Pregnancy: This medication should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking this medication, contact your doctor immediately to talk about the benefits and risks of using this medication.

Breast-feeding: It is not known if fexofenadine passes into breast milk. Women should stop breast-feeding while they are taking this medication.

Children: The safety and effectiveness of using this medication have not been established for children younger than 6 years of age.

For adults and children 12 years of age and older, the usual dose of fexofenadine is 60 mg taken by mouth twice daily or 180 mg taken by mouth once daily. For people with kidney disease, the usual starting dose is 60 mg taken by mouth once daily.

For children aged 6 to 11 years, the usual dose of fexofenadine is 30 mg taken by mouth twice daily. For children with kidney disease, the usual starting dose is 30 mg taken by mouth once daily.

This medication may be taken with or without food.

Store this medication at room temperature, protect it from moisture, and keep it out of the reach of children.

It is important that this medication be taken exactly as prescribed by your doctor. If you miss a dose, take it as soon as possible and continue with your regular schedule. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.

ALLEGRA 30 mg tablets are available in: high-density polyethylene (HDPE) bottles of 100 (NDC 0088-1106-47) with a polypropylene screw cap containing a pulp/wax liner with heat-sealed foil inner seal and HDPE bottles of 500 (NDC 0088-1106-55) with a polypropylene screw cap containing a pulp/wax liner with heat-sealed foil inner seal.

ALLEGRA 60 mg tablets are available in: HDPE bottles of 100 (NDC 0088-1107-47) with a polypropylene screw cap containing a pulp/wax liner with heat-sealed foil inner seal; HDPE bottles of 500 (NDC 0088-1107-55) with a polypropylene screw cap containing a pulp/wax liner with heat-sealed foil inner seal; and aluminum foil-backed clear blister packs of 100 (NDC 0088-1107-49).

ALLEGRA 180 mg tablets are available in: HDPE bottles of 100 (NDC 0088-1109-47) with a polypropylene screw cap containing a pulp/wax liner with heat-sealed foil inner seal and HDPE bottles of 500 (NDC 0088-1109-55) with a polypropylene screw cap containing a pulp/wax liner with heat-sealed foil inner seal.

ALLEGRA tablets are coated with a peach colored film coating. Tablets have the following unique identifiers: 30 mg tablets have 03 on one side and a scripted E on the other; 60 mg tablets have 06 on one side and a scripted E on the other; and 180 mg tablets have 018 on one side and a scripted E on the other.

Store ALLEGRA tablets at controlled room temperature 20–25°C (68–77°F). (See USP Controlled Room Temperature). Foil-backed blister packs containing ALLEGRA tablets should be protected from excessive moisture.

ALLEGRA Oral Suspension (fexofenadine hydrochloride, 30 mg/5mL (6 mg/mL)) is available in amber PET bottles containing 30 mL (NDC 0088-1097-10) and 300 mL (NDC 0088-1097-20) of suspension.

Store ALLEGRA Oral Suspension at controlled room temperature 20–25°C (68–77°F). (See USP Controlled Room Temperature).

Shake bottle well, before each use.